ST2 is listed as a class II indication for the prognosis of heart failure (HF). Soluble ST2 protein (sST2) is a biomarker of vascular health, which has diagnostic and prognostic value for various cardiovascular diseases, including coronary artery disease, myocardial infarction, atherosclerosis, giant cell arteritis, and acute aortic dissection, Ischemic stroke, obesity and diabetes. Myocardial hypertrophy, fibrosis and ventricular dysfunction are related to abnormal levels of sST2.
Yancy et al. (2013) Circulation, 128:1810-1852
Product Specification
Specimen Types |
Serum |
Specimen Capacity |
50μL |
Reaction Time |
15 min |
Sample Capacity |
80μL |
Detection Range |
2-200.0ng/mL |
Simple operation and fast response (15min)
Higher concentration of soluble ST2 is associated with increased myocardial fibrosis, adverse cardiac remodeling, and worse cardiovascular outcomes.
ICU, Respiratory Medicine, Emergency Department, Cardiology, Emergency Car